Hochschulschrift
Investigation of the interaction between Alzheimer's abeta peptide and aggregation inhibitors using molecular simulations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
29 cm
- Umfang
-
159 S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Aachen, Techn. Hochsch., Diss., 2013 (Nicht für den Austausch)
- Klassifikation
-
Medizin, Gesundheit
- Schlagwort
-
Alzheimer-Krankheit, Molekulardynamik, Amyloid , Chemische Verschiebung, Peptide
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:09 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Investigation of the interaction between Alzheimer's abeta peptide and aggregation inhibitors using molecular simulations
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Structural Characterization of Interactions between the Alzheimer’s Disease Amyloid-Beta Peptide and Small Molecules and Peptide Inhibitors
Untersuchungen von Inhibitoren der pathologischen Aggregation des Tau-Proteins bei der Alzheimer Krankheit
Abeta Peptide and Alzheimer's Disease
Extracellular phosphorylation of the Amyloid β-peptide [beta-peptide] promotes aggregation
Beta-Peptide Helices As Transmembrane Domains: Aggregation, Recognition and Lipid-Peptide Interaction
Unfitted finite element simulations based on cell aggregation
Atomistic Simulations of Amyloidogenic Peptides and Their Aggregation
Molecular mechanisms and peptide-based modulators of protein aggregation
Aminopyrazol-Hybridverbindungen gegen Aggregation und Neurotoxizität des Alzheimer-Peptids
Oligomere Aminopyrazole gegen die pathologische Aggregation des "Alzheimer-Peptids"
Investigation of the interaction between Alzheimer's abeta peptide and aggregation inhibitors using molecular simulations
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Structural Characterization of Interactions between the Alzheimer’s Disease Amyloid-Beta Peptide and Small Molecules and Peptide Inhibitors
Untersuchungen von Inhibitoren der pathologischen Aggregation des Tau-Proteins bei der Alzheimer Krankheit
Abeta Peptide and Alzheimer's Disease
Extracellular phosphorylation of the Amyloid β-peptide [beta-peptide] promotes aggregation
Beta-Peptide Helices As Transmembrane Domains: Aggregation, Recognition and Lipid-Peptide Interaction
Unfitted finite element simulations based on cell aggregation
Atomistic Simulations of Amyloidogenic Peptides and Their Aggregation
Molecular mechanisms and peptide-based modulators of protein aggregation
Aminopyrazol-Hybridverbindungen gegen Aggregation und Neurotoxizität des Alzheimer-Peptids
Oligomere Aminopyrazole gegen die pathologische Aggregation des "Alzheimer-Peptids"
Investigation of the interaction between Alzheimer's abeta peptide and aggregation inhibitors using molecular simulations
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Structural Characterization of Interactions between the Alzheimer’s Disease Amyloid-Beta Peptide and Small Molecules and Peptide Inhibitors
Untersuchungen von Inhibitoren der pathologischen Aggregation des Tau-Proteins bei der Alzheimer Krankheit
Abeta Peptide and Alzheimer's Disease
Extracellular phosphorylation of the Amyloid β-peptide [beta-peptide] promotes aggregation
Beta-Peptide Helices As Transmembrane Domains: Aggregation, Recognition and Lipid-Peptide Interaction
Unfitted finite element simulations based on cell aggregation
Atomistic Simulations of Amyloidogenic Peptides and Their Aggregation
Molecular mechanisms and peptide-based modulators of protein aggregation
Aminopyrazol-Hybridverbindungen gegen Aggregation und Neurotoxizität des Alzheimer-Peptids